VERA
VERA
NASDAQ · Biotechnology

Vera Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$36.19
+0.31 (+0.86%)
As of May 9, 1:25 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +161.4% upside
Low Target $72.50
Average Target $94.61
High Target $144.94
Current Price $36.19
Current
$36.19
Target
$94.61
$72.50 $94.61 avg $144.94
Scenario Analysis
Bear Case
$72.50
100.3%
Low target
Base Case
$94.61
+161.4%
Avg target
Bull Case
$144.94
+300.5%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$56.05
-35.4% from high
52-Week Low
$18.76
+92.9% from low
50-Day SMA
$46.91
-22.9% vs SMA
200-Day SMA
$30.68
+18.0% vs SMA
RSI (14)
41.5
Neutral
Target vs 52W High
$94.61
+68.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%